Sign in

CIK 0001527352 · <br>Emerging growth company

Nexalin Technology, Inc.

Sign in to watch
Ticker
NXL
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275566468
Phone
(832) 260-0222
Business address
1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
  1. 4 Grant or award Director acquired 49,838 shares (grant or award)
  2. 4 Grant or award Director acquired 175,000 shares (grant or award)
  3. 4 Grant or award 10% owner acquired 700,000 shares (grant or award)
  4. 4/A Derivatives Options or other derivatives
  5. 8-K Event Delisting notice
  6. 8-K Event Executive or director change
  7. 8-K Event Shareholder vote results
  8. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $0.95 ($950)
  9. 10-Q Report Quarterly Report
  10. 8-K Event Executive or director change
  11. DEF 14A Proxy Proxy Statement
  12. 8-K Event Other events
  13. 8-K Event Material agreement · Other events
  14. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $1.75 ($1,750)
  15. 424B4 Offering Prospectus
  16. 8-K Event Material agreement · Other events
  17. EFFECT Other Notice of Effectiveness
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-1/A Offering Registration Statement

Page 6 of 11 · 206 filings